Drugs / Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate Vaccine
Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01430689 Comparator | Sep 2011 → Jan 2014 | influenza | University of Maryland, Baltimore | Completed | Met primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01430689 ↗ |
| Known as | Menactra - Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine; Product No. 49281-589-05 | “Menactra - Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine; Product No. 49281-589-05” NCT01430689 ↗ |
| Modality | Vaccine | “Quadrivalent Meningococcal Polysaccharide Diphtheria Conjugate Vaccine” NCT01430689 ↗ |
| Route | Intramuscular | “receive IM injection of Menactra once” NCT01430689 ↗ |